Frontier Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,388
| Closed | -$1.5M | – | 274 |
|
|
2021
Q4 | $1.5M | Buy |
7,388
+1,135
| +18% | +$230K | 0.01% | 270 |
|
|
2021
Q3 | $1.69M | Sell |
6,253
-1,538
| -20% | -$414K | 0.01% | 273 |
|
|
2021
Q2 | $2.01M | Sell |
7,791
-21,937
| -74% | -$5.65M | 0.01% | 278 |
|
|
2021
Q1 | $8.92M | Buy |
29,728
+22,873
| +334% | +$6.86M | 0.07% | 230 |
|
|
2020
Q4 | $1.75M | Sell |
6,855
-48,496
| -88% | -$12.4M | 0.01% | 279 |
|
|
2020
Q3 | $13.8M | Sell |
55,351
-4,394
| -7% | -$1.09M | 0.12% | 190 |
|
|
2020
Q2 | $20.8M | Sell |
59,745
-15,335
| -20% | -$5.33M | 0.18% | 163 |
|
|
2020
Q1 | $20.1M | Buy |
75,080
+30,653
| +69% | +$8.21M | 0.23% | 144 |
|
|
2019
Q4 | $14.4M | Sell |
44,427
-8,500
| -16% | -$2.75M | 0.11% | 201 |
|
|
2019
Q3 | $14.5M | Sell |
52,927
-4,615
| -8% | -$1.26M | 0.11% | 199 |
|
|
2019
Q2 | $30.7M | Buy |
57,542
+2,319
| +4% | +$1.24M | 0.23% | 147 |
|
|
2019
Q1 | $27.8M | Buy |
55,223
+2,197
| +4% | +$1.11M | 0.2% | 160 |
|
|
2018
Q4 | $26.1M | Sell |
53,026
-33,526
| -39% | -$16.5M | 0.21% | 148 |
|
|
2018
Q3 | $79.1M | Buy |
86,552
+13,726
| +19% | +$12.6M | 0.51% | 63 |
|
|
2018
Q2 | $53.3M | Buy |
72,826
+27,755
| +62% | +$20.3M | 0.38% | 105 |
|
|
2018
Q1 | $71.8M | Buy |
+45,071
| New | +$71.8M | 0.52% | 62 |
|